Delivery Order SPE2DB22D9353-SPE2DB23FX2KT
Award Date
9/15/23
Potential Completion Date
10/6/23
Potential Value
$4.9K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a $2,925.87 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 0.7 mg OZURDEX implants. The contract has a period of performance from August 1, 2023 through August 22, 2023, with all work to be performed by DMS Pharmaceutical Group Inc. at its facility located in Park Ridge, Illinois. No additional details were provided regarding the original solicitation or whether this...
The Defense Logistics Agency awarded a $975.29 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 0.7 mg OZURDEX implants. The contract has a period of performance from August 17, 2023 through September 8, 2023, with all work taking place in Park Ridge, Illinois. No subcontractors or set aside designations were identified. The Defense Logistics Agency routinely issues delivery orders against various pharmaceutical contracts to support the medical readiness of the U.S....
The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a $1,950.60 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for OZURDEX 0.7 mg implants. The contract has a period of performance from August 7, 2023 through August 28, 2023, with all work to be performed in Park Ridge, Illinois. No additional details were provided regarding the original solicitation or whether this delivery order falls under a larger...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical's indefinite delivery contract for $2,925.87 to supply 0.7 mg OZURDEX implants. The delivery order has a completion date of December 21, 2023 and was awarded on November 30, 2023. No set-aside designation was used for this award. DMS Pharmaceutical Group will fulfill the delivery order from its location in Park Ridge, Illinois as a woman-owned small business...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide OZURDEX 0.7 MG IMPLANTS. The $5,851.74 order has a completion date of December 13, 2023 and was awarded on November 21, 2023. DMS Pharmaceutical Group Inc. will supply the pharmaceutical items to the Defense Logistics Agency Troop Support Medical facility located in Park Ridge, Illinois. No set-aside designation was used for this...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, valued at $2,003.02, is for the delivery of OZURDEX 0.7 MG IMPLANTS. This delivery order is part of a larger indefinite delivery contract, SPE2DB, held by DMS Pharmaceutical Group with the DLA, valued at up to $4,999,999 through the end of 2025. The contract has no set-aside...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,003.02 award is for the delivery of 0.7 mg OZURDEX implants. This order is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which provides a comprehensive range of pharmaceutical items to military health facilities worldwide. The...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $4,006.04 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of OZURDEX 0.7 MG IMPLANTS. This order was placed under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, to provide a comprehensive range of pharmaceutical items in support of military health facilities worldwide. The contract has a period of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,003.02 contract is for the supply of Ozurdex 0.7 mg implants, a specialized pharmaceutical product. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC allows the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,003.02 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of OZURDEX 0.7 MG IMPLANTS, a specialized pharmaceutical product, with a period of performance through December 27, 2024. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the...